Review article: Balancing the ideal versus the practical - Considerations of colorectal cancer prevention and screening

Alimentary Pharmacology and Therapeutics, Supplement

Volumn 19, Issue 1, 2004, Pages 71-76

  Lieberman, D A ^a   Atkin, W ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b ST MARK S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID;

BARIUM ENEMA; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER PREVENTION; CANCER SCREENING; CLINICAL TRIAL; COLONOSCOPY; COLORECTAL CANCER; COMPUTED TOMOGRAPHIC COLONOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EPIDEMIOLOGICAL DATA; HIGH RISK POPULATION; HUMAN; OCCULT BLOOD TEST; PRIORITY JOURNAL; REVIEW; SIGMOIDOSCOPY;

BARIUM SULFATE; COLONOSCOPY; COLORECTAL NEOPLASMS; CONTRAST MEDIA; DNA, NEOPLASM; ENEMA; HUMANS; MASS SCREENING; OCCULT BLOOD; SIGMOIDOSCOPY;

EID: 1342331584     PISSN: 09530673     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Parkin D, Bray F, Devesa S. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001; 37: 4-66.
2. Jamal A, Murray T, Samuels A, et al. Cancer statistics, 2003. CA Cancer J Clin 2003; 53: 5-26.
3. Quinn M, Babb P, Brock A, Kirby E, Jones J. Cancer Trends in England and Wales, 1950-1999. London: The Stationary Office, 2001.
4. Inciardi J, Lee J, Stijnen T. Incidence trends for colorectal cancer in California: Implications for current screening practices. Am J Med 2000; 109: 277-81.
5. Rabeneck L, El-Serag H, Sandler R. Incidence and survival of colorectal cancer in the US 1989-97. Gastroenterology 2001; 120(Suppl. 1): A65 (Abstract).
6. Dunlop M, Farrington S, Carothers A, et al. Cancer risk associated with germline DNA mismatch repair gene-mutations. Hum Mol Genet 1997; 6(1): 105-10.
7. Atkin W, Morson B, Cuzick J. Long-term risk of colorectal cancer after excision of rectosigmoid adenomas. N Engl J Med 1992; 326: 658-62.
8. Lovett E. Family studies in cancer of the colon and rectum. Br J Surg 1976; 63: 533-7.
9. St. John DS, McDermott F, Hopper J, Debney E, Johnson W, Hughes E. Cancer risk in relatives of patients with common colorectal cancer. Ann Intern Med 1993; 118: 785-90.
10. Itzkowitz S. Inflammatory bowel-disease and cancer. Gastroenterol Clin North Am 1997; 26: 129-37.
11. Gatta G, Capocaccia R, Sant M, et al. Understanding variations in survival for colorectal cancer in Europe: a EUROCARE high resolution study. Gut 2000; 47: 533-8.
12. Wingo P, Ries L, Parker S, Heath CW Jr. Long-term cancer patient survival in the United States. Cancer Epidemiol Biomarkers Prev 1998; 7: 271-82.
13. Kronborg O, Fenger C, Olsen J, et al. Randomized study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996; 348: 1467-71.
14. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomized controlled trail of faecal-occult-blood screening for colorectal cancer. Lancet 1996; 348: 1472-7.
15. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993; 328: 1365-71.
16. Ries LAG, Miller BA, Hankey BF, et al. (eds). SEER Cancer Statistics Review, 1973-1991: Tables and Graphs. Bethesda, MD: National Cancer Institute. NIH Publication no. 94-2789, 1904: 51.
17. Muto T, Bussey H, Morson B. The evolution of cancer of the colon and rectum. Cancer 1975; 36: 2251-70.
18. Morson B, Bussey H, Day D, Hill M. Adenomas of large bowel. Cancer Surveys 1983; 2: 451-77.
19. Jass J. Do all colorectal cancers arise in pre-existing adenomas? World J Surg 1989; 74: 45-51.
20. Vogelstein B, Fearson E, Hamilton S, et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988; 319: 525-32.
21. Bond JH. Clinical evidence for the adenoma-carcinoma sequence and the management of patients with colorectal adenomas. Semin Gastrointest Dis 2000; 11: 176-84.
22. Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 1997; 112: 594-642.
23. Rex DK, Hohnson DA, Lieberman DA, et al. Colorectal cancer prevention 2000: Screening recommendations of the American College of Gastroenterology. Am J Gastroenterol 2000; 95: 868-77.
24. Smith RA, Eschenback von AC, Wender R, et al. American Cancer Society Guidelines for early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. CA Cancer J Clin 2001; 51: 38-75.
25. Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: Clinical guidelines and rationale. Gastroenterology [update based on new evidence]. Gastroenterology 2003; 124: 544-60.
26. Screening for colorectal cancer: recommendation and rationale. US Preventative Services Task Force. Ann Intern Med 2002; 137: 129-31.
27. Bond JH. Polyp guideline, diagnosis, treatment, and surveillance for patients with colorectal polyps. Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol 2000; 95: 3053-63.
28. Frazier A, Colditz G, Fuchs C, Kuntz K. Cost-effectiveness of screening for colorectal cancer in the general population. J Am Med Assoc 2000; 284: 1954-61.
29. Lieberman DA, Weiss DG and the VASCP 380 Study Group. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N Engl J Med 2001; 345: 555-60.
30. Imperiale TF, Wagner DR, Lin CY, et al. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med 2000; 343: 169-74.
31. Winawer SJ, Stewart ET, Zauber AG, et al. the NPS Workgroup. A comparison of colonscopy and double-contrast barium enema for surveillance after polypectomy. N Engl J Med 2000; 342: 1766-72.
32. Trends in screening for colorectal cancer - United States, 1997 and 1999. MMWR Morb Mortal Wkly Rep 2001; 50: 162-6.
33. http://www.cancerscreening.nhs.uk
34. Recommendations on cancer screening the European Union. Advisory Committee on Cancer Prevention. Eur J Cancer 2000; 36: 1473-8.
35. Ahlquist DA, Wieland HS, Moertel CG, et al. Accuracy of fecal occult blood screening for colorectal neoplasia: a prospective study using Hemoccult and HemoQuant tests. J Am Med Assoc 1993; 269: 1262-7.
36. Ransohoff DF, Lang CA. Screening for colorectal cancer with the fecal occult blood test: a background paper. American College of Physicians. Ann Intern Med 1997; 126: 811-22.
37. Rozen P, Knaani J, Samuel Z. Eliminating the need for dietary restrictions when using a sensitive guaiac fecal occult blood test. Dig Dis Sci 1999; 44: 756-60.
38. Mandel J, Church T, Ederer F, Bond J. Colorectal cancer mortality: Effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst 1999; 91: 434-7.
39. Muller AD, Sonnenberg A. Prevention of colorectal cancer by flexible endoscopy and polypectomy: a case-control study of 32,702 veterans. Ann Intern Med 1995; 123: 904-10.
40. Newcomb PA, Norfleet RG, Storer BE, et al. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 1992; 84: 1572-5.
41. Atkin W, Edwards R, Wardle J, et al. Design of a multicentre randomized trial to evaluate flexible sigmoidoscopy in colorectal cancer screening. J Med Screen 2001; 8: 137-44.
42. Segnan N, Sciallero S, Bonelli L. Multicentre randomized controlled trial of 'once only' flexible sigmoidoscopy screening in Italy-score. Endoscopy 1999; 31(Suppl. 1): E9.
43. Hoff G, Thiis-Evensen E, Vatn M. Screening for sporadic colorectal cancer. Endoscopy 2002; 34(6): 508; discussion 509-10.
44. Bretthauer M, Gondal G, Larsen K, et al. Design, organization and management of a controlled population screening study for detection of colorectal neoplasia: attendance rates in the NORCCAP study (Norwegian Colorectal Cancer Prevention). Scand J Gastroenterol 2002; 37(5): 568-73.
45. Schoen RE, Pinsky PF, Weissfeld JL, et al. Results of repeat sigmoidoscopy 3 years after a negative examination. JAMA 2003; 290: 41-8.
46. Winawer SJ, Zauber AG, Ho MN, et al. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 1993; 329: 1977-81.
47. Fenlon HM, Nunes DP, Schroy PC, et al. A comparison of virtual and conventional colonscopy for the detection of colorectal polyps. N Engl J Med 1999; 341: 1496-503.
48. Ahlquist DA, Skoletsky JE, Boynton KA, et al. Colorectal cancer screening by detection of altered human DNA in stool: feasibility of a multitarget assay system. Gastroenterology 2000; 119: 1219-27.
49. Tagore K, Ross M, Shuber A, et al. Stool-based DNA multi-target assay for the detection of colorectal cancer and advanced adenomas. Gastroenterology 2002; 122: A-481 (Abstract).
50. Baron JA, Cole BF, Sandler RS, et al. A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med 2003; 348(10): 891-9.
51. Sandler RS, Halabi S, Baron JA, et al. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med 2003; 348(10): 883-90.